However, some health-status outcomes may improve with a low-sodium diet in this population.
The evidence base on dietary interventions for heart failure (HF) has been thin, prompting investigators to conduct the SODIUM-HF trial at 26 sites in 6 countries (NCT02012179). They randomized 806 adults with chronic HF (median age, 67 years; 33% women) who were receiving guideline-directed HF treatment to a diet low in sodium (<1500 mg/day) or usual care. The primary composite outcome was cardiovascular-related hospitalization, cardiovascular-related emergency department visit, or all-cause death within 12 months.
Median sodium intake (assessed by self-report) declined from 2286 mg/day to 1658 mg/day in the intervention group and from 2119 mg/day to 2073 mg/day in the usual-care group. At 12 months, the primary outcome, its components, and…
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association